Latest Breaking News On - Eyepoint pharmaceuticals inc - Page 7 : comparemela.com

Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying - Lindblad Expeditions (NASDAQ:LIND), EyePoint Pharmaceuticals (NASDAQ:EYPT)

Alexp schultzCraig felensteinAdam grayEyepoint pharmaceuticalsSteel connect incMastercraft boat holdings incEyepoint pharmaceuticals incLindblad expeditions holdingsLindblad expeditions holdings incWf asset corpCormorant global healthcare master fundSteel connectSteel connect doesDirect marketingMastercraft boat holdingsMastercraft boat

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Darioa paggiarinoFranklin resources incFirst turn managementNews ratings for eyepoint pharmaceuticals dailyEyepoint pharmaceuticalsSecurities exchange commissionJpmorgan chase coEyepoint pharmaceuticals incEyepoint pharmaceuticals stockInstitutional investors weigh in on eyepoint pharmaceuticalsHermes incJennison associatesGet free reportPoint pharmaceuticalsExchange commissionCormorant asset management

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China universal asset management coSecurities exchange commissionQuarter for eyepoint pharmaceuticalsJpmorgan chase coEyepoint pharmaceuticals incNews ratings for eyepoint pharmaceuticals dailySherbrooke park advisersEyepoint pharmaceuticals price performanceTower research capitalEyepoint pharmaceuticalsInvestment advisersHedge funds weigh in on eyepoint pharmaceuticalsToth financial advisory corpGet free reportCormorant asset managementExchange commission

DelveInsight Business Research, LLP: Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19 8% by 2034

DelveInsight Business Research, LLP: Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19 8% by 2034
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomExegenesis bioIveric bioCellcure neurosciencesAscentage pharmaBelite bioDennis riedlAnnexon biosciencesShruti thakurClearside biomedical incMarket researchAmerican academy of ophthalmologyEuropean society of retina specialistsAshvattha therapeutics incAffamed therapeutics

Cormorant Asset Management, Lp Buys 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock

Cormorant Asset Management, Lp Buys 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hermes incFranklin resources incEyepoint pharmaceuticalsEyepoint pharmaceuticals company profileHedge funds weigh in on eyepoint pharmaceuticalsFirst turn managementJennison associatesJpmorgan chase coEyepoint pharmaceuticals incNews ratings for eyepoint pharmaceuticals dailySecurities exchange commissionQuarter for eyepoint pharmaceuticalsEyepoint pharmaceuticals stock performanceGet free reportCormorant asset managementExchange commission